Ligand-specific sequential regulation of transcription factors for differentiation of MCF-7 cells

BackgroundSharing a common ErbB/HER receptor signaling pathway, heregulin (HRG) induces differentiation of MCF-7 human breast cancer cells while epidermal growth factor (EGF) elicits proliferation. Although cell fates resulting from action of the aforementioned ligands completely different, the respective gene expression profiles in early transcription are qualitatively similar, suggesting that gene expression during late transcription, but not early transcription, may reflect ligand specificity. In this study, based on both the data from time-course quantitative real-time PCR on over 2,000 human transcription factors and microarray of all human genes, we identified a series of transcription factors which may control HRG-specific late transcription in MCF-7 cells.ResultsWe predicted that four transcription factors including EGR4, FRA-1, FHL2, and DIPA should have responsibility of regulation in MCF-7 cell differentiation. Validation analysis suggested that one member of the activator protein 1 (AP-1) family, FOSL-1 (FRA-1 gene), appeared immediately following c-FOS expression, might be responsible for expression of transcription factor FHL2 through activation of the AP-1 complex. Furthermore, RNAi gene silencing of FOSL-1 and FHL2 resulted in increase of extracellular signal-regulated kinase (ERK) phosphorylation of which duration was sustained by HRG stimulation.ConclusionOur analysis indicated that a time-dependent transcriptional regulatory network including c-FOS, FRA-1, and FHL2 is vital in controlling the ERK signaling pathway through a negative feedback loop for MCF-7 cell differentiation.

[1]  M. Greenberg,et al.  Nerve growth factor and epidermal growth factor induce rapid transient changes in proto-oncogene transcription in PC12 cells. , 1985, The Journal of biological chemistry.

[2]  J. Milbrandt.  Nerve growth factor rapidly induces c-fos mRNA in PC12 rat pheochromocytoma cells. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[3]  T. Curran,et al.  fra-1: a serum-inducible, cellular immediate-early gene that encodes a fos-related antigen , 1988, Molecular and cellular biology.

[4]  P. Vogt,et al.  The avian cellular homolog of the oncogene jun. , 1988, Oncogene.

[5]  D. Anderson,et al.  The induction of a neural-specific gene, SCG10, by nerve growth factor in PC12 cells is transcriptional, protein synthesis dependent, and glucocorticoid inhibitable. , 1988, Developmental biology.

[6]  D. Nathans,et al.  jun-D: a third member of the jun gene family. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[7]  M. Zerial,et al.  The product of a novel growth factor activated gene, fos B, interacts with JUN proteins enhancing their DNA binding activity. , 1989, The EMBO journal.

[8]  M. Yaniv,et al.  Characterization of junD: a new member of the jun proto‐oncogene family. , 1989, The EMBO journal.

[9]  H. Mehmet,et al.  Multiple synergistic signal transduction pathways regulate c-fos expression in Swiss 3T3 cells: the role of cyclic AMP. , 1990, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[10]  N. Nomura,et al.  Isolation of human fos-related genes and their expression during monocyte-macrophage differentiation. , 1990, Oncogene.

[11]  H. Iba,et al.  Isolation and characterization of fra-2, an additional member of the fos gene family. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[12]  R. Bravo,et al.  Expression of different Jun and Fos proteins during the G0-to-G1 transition in mouse fibroblasts: in vitro and in vivo associations , 1991, Molecular and cellular biology.

[13]  M. Karin,et al.  The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. , 1991, Biochimica et biophysica acta.

[14]  R. Bravo,et al.  Existence of different Fos/Jun complexes during the G0-to-G1 transition and during exponential growth in mouse fibroblasts: differential role of Fos proteins , 1992, Molecular and cellular biology.

[15]  E. Van Obberghen,et al.  Differential activation of p44mapk (ERK1) by alpha-thrombin and thrombin-receptor peptide agonist. , 1993, The Biochemical journal.

[16]  H. Iba,et al.  Cloning and characterisation of the mouse fra-2 gene. , 1994, Oncogene.

[17]  M. Busslinger,et al.  Transcriptional activation of the fra-1 gene by AP-1 is mediated by regulatory sequences in the first intron , 1995, Molecular and cellular biology.

[18]  S. Cook,et al.  Kinetic and biochemical correlation between sustained p44ERK1 (44 kDa extracellular signal-regulated kinase 1) activation and lysophosphatidic acid-stimulated DNA synthesis in Rat-1 cells. , 1996, The Biochemical journal.

[19]  R. Brazas,et al.  A Cellular Homolog of Hepatitis Delta Antigen: Implications for Viral Replication and Evolution , 1996, Science.

[20]  H. Iba,et al.  Phosphorylation and high level expression of Fra-2 in v-src transformed cells: a pathway of activation of endogenous AP-1 , 1997, Oncogene.

[21]  E. Wagner,et al.  Structure and chromosomal assignment of the mouse fra-1 gene, and its exclusion as a candidate gene for oc (osteosclerosis) , 1997, Oncogene.

[22]  P. Zipfel,et al.  The human zinc finger protein EGR-4 acts as autoregulatory transcriptional repressor. , 1997, Biochimica et biophysica acta.

[23]  J. Baldassare,et al.  Sustained activation of extracellular-signal-regulated kinase 1 (ERK1) is required for the continued expression of cyclin D1 in G1 phase. , 1997, The Biochemical journal.

[24]  M. Yaniv,et al.  Transformation by ras modifies AP1 composition and activity , 1997, Oncogene.

[25]  M. Bottazzi,et al.  α5β1 Integrin Controls Cyclin D1 Expression by Sustaining Mitogen-activated Protein Kinase Activity in Growth Factor-treated Cells , 1999 .

[26]  C. Marshall,et al.  Activated MEK Stimulates Expression of AP-1 Components Independently of Phosphatidylinositol 3-Kinase (PI3-Kinase) but Requires a PI3-Kinase Signal To Stimulate DNA Synthesis , 1999, Molecular and Cellular Biology.

[27]  K Kornfeld,et al.  Multiple docking sites on substrate proteins form a modular system that mediates recognition by ERK MAP kinase. , 1999, Genes & development.

[28]  H. Iba,et al.  Fra-2-positive autoregulatory loop triggered by mitogen-activated protein kinase (MAPK) and Fra-2 phosphorylation sites by MAPK. , 1999, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[29]  Andrius Kazlauskas,et al.  Diverse Signaling Pathways Activated by Growth Factor Receptors Induce Broadly Overlapping, Rather Than Independent, Sets of Genes , 1999, Cell.

[30]  S. Cook,et al.  The Repertoire of Fos and Jun Proteins Expressed during the G1 Phase of the Cell Cycle Is Determined by the Duration of Mitogen-Activated Protein Kinase Activation , 1999, Molecular and Cellular Biology.

[31]  S. Cook,et al.  Sustained MAP kinase activation is required for the expression of cyclin D1, p21Cip1 and a subset of AP-1 proteins in CCL39 cells , 1999, Oncogene.

[32]  M. Bottazzi,et al.  Alpha5beta1 integrin controls cyclin D1 expression by sustaining mitogen-activated protein kinase activity in growth factor-treated cells. , 1999, Molecular biology of the cell.

[33]  D. Saffen,et al.  Nerve growth factor induces zif268 gene expression via MAPK-dependent and -independent pathways in PC12D cells. , 1999, Journal of biochemistry.

[34]  P. Sassone-Corsi,et al.  A Family of LIM-Only Transcriptional Coactivators: Tissue-Specific Expression and Selective Activation of CREB and CREM , 2000, Molecular and Cellular Biology.

[35]  E. Wagner,et al.  Fosl1 is a transcriptional target of c-Fos during osteoclast differentiation , 2000, Nature Genetics.

[36]  H. Band,et al.  The Evolutionarily Conserved N-terminal Region of Cbl Is Sufficient to Enhance Down-regulation of the Epidermal Growth Factor Receptor* , 2000, The Journal of Biological Chemistry.

[37]  M. Ashburner,et al.  Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.

[38]  E. Tulchinsky,et al.  Fos family members: regulation, structure and role in oncogenic transformation. , 2000, Histology and histopathology.

[39]  J. Reusch,et al.  CREB Activation Induces Adipogenesis in 3T3-L1 Cells , 2000, Molecular and Cellular Biology.

[40]  S. Ethier,et al.  Identification of gene expression profiles that predict the aggressive behavior of breast cancer cells. , 2001, Cancer research.

[41]  T. Kerppola,et al.  Close encounters of many kinds: Fos-Jun interactions that mediate transcription regulatory specificity , 2001, Oncogene.

[42]  E. Wagner,et al.  Promoter Specificity and Biological Activity of Tethered AP-1 Dimers , 2002, Molecular and Cellular Biology.

[43]  Rey-Huei Chen,et al.  Molecular interpretation of ERK signal duration by immediate early gene products , 2002, Nature Cell Biology.

[44]  P. Verde,et al.  Accumulation of Fra-1 in ras-Transformed Cells Depends on Both Transcriptional Autoregulation and MEK-Dependent Posttranslational Stabilization , 2003, Molecular and Cellular Biology.

[45]  S. Reddy,et al.  Multiple cis-Elements Mediate the Transcriptional Activation of Human fra-1 by 12-O-Tetradecanoylphorbol-13-acetate in Bronchial Epithelial Cells* , 2003, Journal of Biological Chemistry.

[46]  C. Marshall,et al.  Elevated ERK-MAP kinase activity protects the FOS family member FRA-1 against proteasomal degradation in colon carcinoma cells , 2003, Journal of Cell Science.

[47]  P. Sassone-Corsi,et al.  The LIM-only protein FHL2 is a serum-inducible transcriptional coactivator of AP-1 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[48]  A. Levine,et al.  Cutting Edge: Extracellular Signal-Regulated Kinases 1/2 Function as Integrators of TCR Signal Strength 1 , 2004, The Journal of Immunology.

[49]  Jeffrey P. MacKeigan,et al.  A Network of Immediate Early Gene Products Propagates Subtle Differences in Mitogen-Activated Protein Kinase Signal Amplitude and Duration , 2004, Molecular and Cellular Biology.

[50]  Y. Hayashizaki,et al.  Identification of region‐specific transcription factor genes in the adult mouse brain by medium‐scale real‐time RT‐PCR , 2004, FEBS letters.

[51]  R. Schüle,et al.  Extracellular Signal-Regulated Kinase 2 Interacts with and Is Negatively Regulated by the LIM-Only Protein FHL2 in Cardiomyocytes , 2004, Molecular and Cellular Biology.

[52]  Andreas Krause,et al.  A standard curve based method for relative real time PCR data processing , 2005, BMC Bioinformatics.

[53]  Ulrich Siebenlist,et al.  Early growth response proteins EGR-4 and EGR-3 interact with immune inflammatory mediators NF-κB p50 and p65 , 2005, Journal of Cell Science.

[54]  K. Kristiansen,et al.  Delta-interacting Protein A, a New Inhibitory Partner of CCAAT/Enhancer-binding Protein β, Implicated in Adipocyte Differentiation* , 2005, Journal of Biological Chemistry.

[55]  S. Reddy,et al.  Mitogen regulated induction of FRA-1 proto-oncogene is controlled by the transcription factors binding to both serum and TPA response elements , 2005, Oncogene.

[56]  Jeffrey T. Chang,et al.  GATHER: a systems approach to interpreting genomic signatures , 2006, Bioinform..

[57]  P. Ascenzi,et al.  Estrogen signaling multiple pathways to impact gene transcription. , 2006, Current genomics.

[58]  Zefei Jiang,et al.  An association of a simultaneous nuclear and cytoplasmic localization of Fra-1 with breast malignancy , 2006, BMC Cancer.

[59]  S. Dedieu,et al.  Retinoids interfere with the AP1 signalling pathway in human breast cancer cells. , 2006, Cellular signalling.

[60]  Liliane A. T. Arnaldi,et al.  FRA-1 protein overexpression is a feature of hyperplastic and neoplastic breast disorders , 2007, BMC Cancer.

[61]  B. Jiang,et al.  Suppression of FHL2 expression induces cell differentiation and inhibits gastric and colon carcinogenesis. , 2007, Gastroenterology.

[62]  P. Bastiaens,et al.  Growth factor-induced MAPK network topology shapes Erk response determining PC-12 cell fate , 2007, Nature Cell Biology.

[63]  S. Cook,et al.  The duration of ERK1/2 activity determines the activation of c-Fos and Fra-1 and the composition and quantitative transcriptional output of AP-1. , 2007, Cellular signalling.

[64]  M. Eriksson,et al.  Mitogen activated protein kinase‐dependent activation of c‐Jun and c‐Fos is required for neuronal differentiation but not for growth and stress response in PC12 cells , 2007, Journal of cellular physiology.

[65]  B. Kholodenko,et al.  Ligand-dependent responses of the ErbB signaling network: experimental and modeling analyses , 2007, Molecular systems biology.

[66]  A. Konagaya,et al.  Integrative Genome-Wide Expression Analysis Bears Evidence of Estrogen Receptor-Independent Transcription in Heregulin-Stimulated MCF-7 Cells , 2008, PLoS ONE.

[67]  H. Nam,et al.  TNF alpha-induced down-regulation of estrogen receptor alpha in MCF-7 breast cancer cells. , 2008, Molecules and cells.